Oropharyngeal Cancer Clinical Trial
Official title:
Physiotherapy Versus no Physiotherapy to Patients Suffering From Head and Neck Cancer Undergoing Radiotherapy Treatment
The purpose of this study is to investigate whether the extent of late sequelae symptoms(reduced mouth opening, lymphoedema, decreased range of motion in the neck and shoulder region, speech and swallow disorders and reduced facial expression) due to radiotherapy treatment for head and neck cancer can be reduced by an individually adjusted physiotherapy effort applied immediately after the onset of and during radiotherapy treatment.
In Denmark there are about 1000 new cases of head and neck cancer every year. The number is
increasing. The treatment for head and neck cancer is either surgery or radiotherapy
treatment or a combination of these modalities. Radiotherapy treatment for head and neck
cancer often causes severe late term side effects.
Radiotherapy induced damage of the skin, lymphatic system, cartilage and bone often leads to
symptoms such as trismus, lymphoedema, decreased range of motion of the mouth, neck and
tongue, difficulty in using the mimic muscles, difficulty in swallowing and pain. The
severity of late side effects due to radiotherapy treatment for head and neck cancer often
leaves the patients with a poor quality of life rating.
Effects of physiotherapy interventions are scarcely investigated. Only few studies describe
the effect of physiotherapy treatment. The studies are difficult to compare because of
insufficiently described physiotherapy intervention, or variation of onset and extent of
physiotherapy intervention plus variation in study populations. No studies have described
the long term effects of physiotherapy intervention. There is no national or international
consensus for the physiotherapy treatment for patients undergoing treatment for head and
neck cancer.
Primary hypothesis:
Decreased mouth opening in patients suffering from c.cavi oris and c.oropharynges undergoing
radiotherapy treatment, can be reduced by an early physiotherapy effort compared with the
present circumstances.
Secondary hypothesis:
The extent of late side effects from radiotherapy treatment for head and neck cancer can be
reduced by an early and individually adjusted physiotherapy treatment.
Guided physiotherapy training/treatment can have a positive effect on patients self
estimated symptom extent and health related quality af life.
The hypothesis of this study is built on studies of literature and clinical experience from
treatment of late side effects on patients suffering from breast cancer and uterus cancer,
who also suffer from lymphoedema and fibrosis due to radiotherapy.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Prevention
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT03656133 -
Use of a Proliferation Saturation Index to Determine Personalized Radiotherapy for HPV + Oropharyngeal Cancers
|
N/A | |
Terminated |
NCT02225496 -
Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma
|
Phase 2 | |
Withdrawn |
NCT01767961 -
Modified Barium Swallow in Measuring Swallowing Function After Surgery in Patients With Oropharyngeal Cancer
|
N/A | |
Completed |
NCT01695122 -
Valproic Acid and Platinum-based Chemoradiation in Locally Advanced Head and Neck Squamous Cell Carcinoma
|
Phase 2 | |
Completed |
NCT01435252 -
A Phase II Study In Patients With Advanced Head And Neck Cancer Of Standard Chemoradiation And Add-On Cetuximab
|
Phase 2 | |
Recruiting |
NCT04708470 -
A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers
|
Phase 1/Phase 2 | |
Withdrawn |
NCT00951470 -
Complete Decongestive Therapy (CDT) for Treatment of Head and Neck Lymphedema
|
N/A | |
Completed |
NCT01358097 -
Role of Immune Activation in Response of Head and Neck Squamous Cell Carcinoma to Therapy
|
N/A | |
Completed |
NCT01342978 -
Human Papillomavirus (HPV) Oral Transmission Study in Partners Over Time
|
N/A | |
Completed |
NCT00964977 -
Effectiveness of Adjuvant Radiotherapy in Small Oropharyngeal Squamous Cell Cancer and Single Lymph Node Metastasis.
|
Phase 3 | |
Recruiting |
NCT05363709 -
BALSTILIMAB on Viral Clearance in HPV+ Oropharyngeal Cancer Patients
|
Phase 2 | |
Completed |
NCT02280811 -
T Cell Receptor Immunotherapy Targeting HPV-16 E6 for HPV-Associated Cancers
|
Phase 2 | |
Active, not recruiting |
NCT03777384 -
EValuating the Safety Of De-escaLated Head and Neck Irradiation in HPV positivE Oropharynx Cancer in Non-smokers/Minimal Smokers
|
||
Active, not recruiting |
NCT03729518 -
TORS De-Intensification Protocol Version 2.0: Dose and Volume Reduction in the Neck
|
N/A | |
Recruiting |
NCT06121102 -
Standard Pulsed Radiofrequency Versus Supervoltage Pulsed Radiofrequency Glossopharyngeal Nerve in Oropharyngeal Cancer Pain
|
N/A | |
Recruiting |
NCT02984410 -
Study Assessing The "Best of" Radiotherapy vs the "Best of" Surgery in Patients With Oropharyngeal Carcinoma
|
N/A | |
Recruiting |
NCT02960724 -
uPAR PET/CT for Staging Advanced and Localised Oral and Oropharyngeal Cancer
|
Phase 2 | |
Completed |
NCT02934724 -
Impact of HPV Vaccine On The Prevalence Of HPV In Norway
|
||
Withdrawn |
NCT00928161 -
Reflux Disease in Head and Neck Cancer Patients Undergoing Radiation Therapy
|
N/A | |
Recruiting |
NCT02012699 -
Integrated Cancer Repository for Cancer Research
|